194 related articles for article (PubMed ID: 15492813)
1. Subcellular localization of MUC1 recognized by a monoclonal antibody MY.1E12 correlates with postsurgical prognosis in differentiated-type gastric carcinomas of stage II and III.
Shinozaki E; Adachi S; Shoda J; Kawamoto T; Suzuki H; Irimura T; Ohkohchi N
Int J Oncol; 2004 Nov; 25(5):1257-65. PubMed ID: 15492813
[TBL] [Abstract][Full Text] [Related]
2. Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
Kawamoto T; Shoda J; Irimura T; Miyahara N; Furukawa M; Ueda T; Asano T; Kano M; Koike N; Fukao K; Tanaka N; Todoroki T
Clin Cancer Res; 2001 May; 7(5):1333-42. PubMed ID: 11350903
[TBL] [Abstract][Full Text] [Related]
3. Expression of MUC1 recognized by a monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of carcinoma of the gallbladder.
Kawamoto T; Shoda J; Miyahara N; Suzuki H; Furukawa M; Todoroki T; Tanaka N; Irimura T
Clin Exp Metastasis; 2004; 21(4):353-62. PubMed ID: 15554392
[TBL] [Abstract][Full Text] [Related]
4. Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma.
Suzuki H; Shoda J; Kawamoto T; Shinozaki E; Miyahara N; Hotta S; Iizuka Y; Nakahara A; Tanaka N; Yanaka A; Irimura T
Clin Exp Metastasis; 2004; 21(4):321-9. PubMed ID: 15554388
[TBL] [Abstract][Full Text] [Related]
5. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
[TBL] [Abstract][Full Text] [Related]
6. Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy.
Tanaka M; Kitajima Y; Sato S; Miyazaki K
Br J Surg; 2003 Jan; 90(1):95-101. PubMed ID: 12520583
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of carbohydrate antigen 19-9 in gastric carcinoma.
Ikeda Y; Mori M; Kido A; Shimono R; Matsushima T; Sugimachi K; Saku M
Am J Gastroenterol; 1991 Sep; 86(9):1163-6. PubMed ID: 1882795
[TBL] [Abstract][Full Text] [Related]
8. Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas.
Wang JY; Chang CT; Hsieh JS; Lee LW; Huang TJ; Chai CY; Lin SR
J Surg Oncol; 2003 Aug; 83(4):253-60. PubMed ID: 12884239
[TBL] [Abstract][Full Text] [Related]
9. Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients.
Fujita K; Denda K; Yamamoto M; Matsumoto T; Fujime M; Irimura T
Br J Cancer; 1999 Apr; 80(1-2):301-8. PubMed ID: 10390012
[TBL] [Abstract][Full Text] [Related]
10. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the expression of MUC1 and collagen type IV in advanced gastric carcinoma.
Ando H; Aihara R; Ohno T; Ogata K; Mochiki E; Kuwano H
Br J Surg; 2009 Aug; 96(8):901-9. PubMed ID: 19591170
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic significance of sialyl Le(x) expression in advanced gastric carcinoma.
Futamura N; Nakamura S; Tatematsu M; Yamamura Y; Kannagi R; Hirose H
Br J Cancer; 2000 Dec; 83(12):1681-7. PubMed ID: 11104566
[TBL] [Abstract][Full Text] [Related]
13. Expression of sialylated MUC1 in prostate cancer: relationship to clinical stage and prognosis.
Arai T; Fujita K; Fujime M; Irimura T
Int J Urol; 2005 Jul; 12(7):654-61. PubMed ID: 16045558
[TBL] [Abstract][Full Text] [Related]
14. Biological and therapeutic significance of MUC1 with sialoglycans in clear cell adenocarcinoma of the ovary.
Tamada Y; Takeuchi H; Suzuki N; Susumu N; Aoki D; Irimura T
Cancer Sci; 2007 Oct; 98(10):1586-91. PubMed ID: 17711507
[TBL] [Abstract][Full Text] [Related]
15. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
[TBL] [Abstract][Full Text] [Related]
16. Gastric cancer histology: clinicopathologic characteristics and prognostic value.
Park JM; Jang YJ; Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS
J Surg Oncol; 2008 Dec; 98(7):520-5. PubMed ID: 18802956
[TBL] [Abstract][Full Text] [Related]
17. Gastric cancer: correlation between clinicopathological factors and survival of patients. II.
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(2):185-94. PubMed ID: 19434309
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer.
Ohno T; Aihara R; Kamiyama Y; Mochiki E; Asao T; Kuwano H
Eur J Cancer; 2006 Jan; 42(2):256-63. PubMed ID: 16356709
[TBL] [Abstract][Full Text] [Related]
19. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
[TBL] [Abstract][Full Text] [Related]
20. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]